GILL PARKASH has a total of 15 patent applications. It decreased the IP activity by 100.0%. Its first patent ever was published in 2004. It filed its patents most often in WIPO (World Intellectual Property Organization), United States and China. Its main competitors in its focus markets pharmaceuticals, biotechnology and measurement are SHANGHAI ZHANGJIANG BIOTECHNOLOGY CO LTD, PHOENIX PHARMACEUTICALS INC and BIOSCEPTRE INTERNATIONAL LTD.
# | Country | Total Patents | |
---|---|---|---|
#1 | WIPO (World Intellectual Property Organization) | 6 | |
#2 | United States | 5 | |
#3 | China | 1 | |
#4 | Republic of Korea | 1 | |
#5 | Peru | 1 | |
#6 | Singapore | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Measurement |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Peptides | |
#3 | Medical preparations | |
#4 | Analysing materials | |
#5 | Microorganisms | |
#6 | Measuring microorganism processes |
# | Name | Total Patents |
---|---|---|
#1 | Gill Parkash | 15 |
#2 | Liu Ren | 9 |
#3 | Krasnoperov Valery | 5 |
#4 | Reddy Ramachandra | 3 |
#5 | Carr Francis Joseph | 1 |
#6 | Kertesz Nathalie | 1 |
#7 | Sood Anil K | 1 |
#8 | Jones Timothy David | 1 |
#9 | Zozulya Sergey | 1 |
#10 | Keen Simon William | 1 |
Publication | Filing date | Title |
---|---|---|
CN105452292A | Cancer treatment using antibodies that bind cell surface GRP78 | |
US2009035308A1 | Methods for using and identifying modulators of Delta-like 4 |